Europe In the wake of the COVID-19 crisis and the subsequent strain placed on medicine supply chains in Europe, Sandoz – the generics arm of global giant Novartis – has moved to strengthen its antibiotics manufacturing presence in Austria. The planned combined investment of EUR 150 million by Sandoz and…
See our Cookie Privacy Policy Here